You are here: Industry Insights > Mylan

News List

Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for L expresspharma
June 02, 2020
Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Mylan partners with Gilead to manufacture remdesivir, potential COVID-19 treatment europeanpharmaceuticalreview
May 15, 2020
According to a new agreement between Mylan and Gilead, the former has the rights to manufacture and distribute remdesivir in 127 countries, a drug being tested to combat COVID-19.
Mylan to Supply Remdesivir for Potential Treatment of COVID-19 americanpharmaceuticalreview
May 14, 2020
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
Gilead, Mylan Ink Global Remdesivir License Agreement contractpharma
May 13, 2020
To supply Remdesivir for potential COVID-19 treatment in 127 low- and middle-income countries.
Biocon and Mylan launch fulphila — biosimilar to pegfilgrastim, in Canada expresspharma
April 29, 2020
The approval of fulphila was based on a comprehensive package of analytical, non-clinical and clinical data, which confirmed that the product is highly similar to neulasta and no clinically meaningful differences in terms of safety and efficacy exist.
Mylan Board Announces Executive Chairman Appointment americanpharmaceuticalreview
April 17, 2020
The Mylan Board of Directors announced the appointment of Robert J. Coury, previously chairman of the Mylan Board, to the position of executive chairman of Mylan, effective immediately.
Biocon and Mylan Launch Fulphila, Biosimilar Pegfilgrastim, in Australia expresspharma
April 15, 2020
The approval of Fulphila was based on a comprehensive package of analytical, nonclinical and clinical data, which confirmed that the product is highly similar to Neulasta and no clinically meaningful differences in terms of safety and efficacy exist.
Mylan Updates COVID-19 Response americanpharmaceuticalreview
April 14, 2020
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
Mylan, Lupin Announce Positive CHMP Opinion for Biosimilar Nepexto americanpharmaceuticalreview
April 01, 2020
Mylan and Lupin announced the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Nepexto® ...
Mylan Waives Marketing Exclusivity in US for Lopinavir/Ritonavir for COVID-19 Needs americanpharmaceuticalreview
March 31, 2020
Mylan announced, in its ongoing effort to support patients and public health needs in the current circumstances surrounding the COVID-19 pandemic.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page